Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hardman

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
European Journal of Heart Failure|May 31, 2018
Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and JapanToshiyuki Nagai, Varun Sundaram, Ahmad Shoaib, et al.
Open Heart|September 20, 2018
Mortality after admission for heart failure in the UK compared with JapanToshiyuki Nagai, Varun Sundaram, Kieran Rothnie, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 25, 2019
Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitusLeocadio Rodriguez-Mañas, Olga Laosa, Bruno Vellas, et al.
Expert Review of Respiratory Medicine|June 9, 2026
Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID19: a multicenter, randomized, double-blind, placebo-controlled studySergey N Avdeev, Galina L Ignatova, Oxana M Drapkina, et al.
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Trials|January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trialCatherine E Hanratty, John G Matthews, Joseph R Arron, et al.
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma controlXue Zeng, Jing Qing, Chi-Ming Li, et al.
Geroscience|February 18, 2021
A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohortsDavid Gomez-Cabrero, Stefan Walter, Imad Abugessaisa, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Heart Failure|May 31, 2018
Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and JapanToshiyuki Nagai, Varun Sundaram, Ahmad Shoaib, et al.
Open Heart|September 20, 2018
Mortality after admission for heart failure in the UK compared with JapanToshiyuki Nagai, Varun Sundaram, Kieran Rothnie, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 25, 2019
Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitusLeocadio Rodriguez-Mañas, Olga Laosa, Bruno Vellas, et al.
Expert Review of Respiratory Medicine|June 9, 2026
Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID19: a multicenter, randomized, double-blind, placebo-controlled studySergey N Avdeev, Galina L Ignatova, Oxana M Drapkina, et al.
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 9, 2023
A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by SexMatthew C Eastwood, John Busby, David J Jackson, et al.
Trials|January 6, 2018
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trialCatherine E Hanratty, John G Matthews, Joseph R Arron, et al.
The Lancet. Respiratory Medicine|September 11, 2020
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trialLiam G Heaney, John Busby, Catherine E Hanratty, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma controlXue Zeng, Jing Qing, Chi-Ming Li, et al.
Geroscience|February 18, 2021
A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohortsDavid Gomez-Cabrero, Stefan Walter, Imad Abugessaisa, et al.
Pageof 14